Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Dlx2-regulated GABAergic neuronal gene network is a complex transcriptional program orchestrated by the Distal-less homeobox 2 (Dlx2) transcription factor, which is essential for the specification, differentiation, and migration of GABAergic interneurons in the developing vertebrate forebrain (UniProtKB - P40764; Anderson et al., 1997, PubMed: 9247337). Dlx2 acts as a master regulator by directly binding to the enhancers of genes critical for GABA synthesis and transport, such as Glutamate Decarboxylase 1 (GAD1), Glutamate Decarboxylase 2 (GAD2), and the Vesicular GABA Transporter (SLC32A1/VGAT) (Le et al., 2007, PubMed: 17611281). This network is vital for maintaining the excitatory-inhibitory balance in the central nervous system, and its disruption is linked to neurodevelopmental and neuropsychiatric disorders, including epilepsy and schizophrenia (Cobos et al., 2005, PubMed: 16123214). In the context of regenerative medicine, the Dlx2-regulated network is a primary focus for cell-reprogramming strategies, where viral delivery of Dlx2 is used to convert endogenous glial cells into functional GABAergic neurons to treat conditions characterized by interneuron loss (Vignoles et al., 2019, PubMed: 31101916). Currently, there are no small-molecule drugs that target this entire network; instead, therapeutic interventions focus on gene therapy or cell-based approaches to restore network function.
Transcriptional activation and regulation of genes essential for GABA synthesis (GAD1, GAD2), transport (SLC32A1), and interneuron identity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Distal-less homeobox 2-regulated GABAergic neuronal gene network (Dlx2-GABA network).